Myasthenia gravis (MG): Epidemiological data and prognostic factors

Annals of the New York Academy of Sciences

Volumn 998, Issue , 2003, Pages 413-423

  Mantegazza, Renato ^a   Baggi, Fulvio ^a   Antozzi, Carlo ^a   Confalonieri, Paolo ^a   Morandi, Lucia ^a   Bernasconi, Pia ^a   Andreetta, Francesca ^a   Simoncini, Ornella ^a   Campanella, Angela ^a   Beghi, Ettore ^b   Cornelio, Ferdinando ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Database; Diagnosis; Myasthenia gravis (MG); Prognostic factor

Indexed keywords

ADULT; AGED; BULBAR PARALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIPLOPIA; EYE DISEASE; FEMALE; FOLLOW UP; GENDER; HEALTH HAZARD; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MULTIVARIATE ANALYSIS; MYASTHENIA GRAVIS; OUTPATIENT DEPARTMENT; POPULATION; PROGNOSIS; REMISSION; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOM; THORACOSCOPY; THYMECTOMY; THYMUS HYPERPLASIA; THYROID SURGERY; TREATMENT OUTCOME;

EID: 0141504280     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1254.054     Document Type: Conference Paper

References (12)

1. OOSTERHUIS, H.J.G.H. 1997. Clinical aspects and epidemiology. In Myasthenia Gravis, pp. 17-48. Groningen Neurological Press. Groningen.
2. GROB, D., N.G. BRUNNER & T. NAMBA. 1981. The natural course of myasthenia gravis and effect of therapeutic measures. Ann. N.Y. Acad. Sci. 377: 652-669.
3. PHILLIPS, L.H. & J.C. TORNER. 1996. Epidemiological evidence for a changing natural history of myasthenia gravis. Neurology 47: 1233-1238.
4. MANTEGAZZA, R. et al. 1990. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J. Neurol. 237: 339-344.
5. BEGHI, E. et al. 1991. Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J. Neurol. Sci. 106: 213-220.
6. MANTEGAZZA, R. et al. 1988. Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J. Neurol. 235: 449-453.
7. YOUNGER, D.S., B.B. WORRALL & A.S. PENN. 1997. Myasthenia gravis: historical perspective and overview. Neurology 48(suppl. 5): S1-S7.
8. BEESON, D., L. JACOBSON, J. NEWSOM-DAVIS & A. VINCENT. 1996. A transfected human muscle cell line expressing the adult type of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis. Neurology 47: 1552-1555.
9. TASK FORCE OF THE MEDICAL SCIENTIFIC ADVISORY BOARD OF THE MYASTHENIA GRAVIS FOUNDATION OF AMERICA. 2000. Myasthenia gravis: recommendations for clinical research standards. Neurology 55: 16-23.
10. KAPLAN, E.L. & P. MEIER. 1958. Nonparametric estimation for incomplete observations. J. Am. Stat. Assoc. 53: 457-481.
11. COX, D.R. 1972. Regression model and life tables. J. R. Stat. Soc. B34: 187-220.
12. ANTOZZI, C. et al. 1991. A short plasma exchange protocol is effective in severe myasthenia gravis. J. Neurol. 238: 103-107.